Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics

por Lee, Myongjae, Jeong, Yoo-Seong, Kim, Min-Soo, An, Kyung-Mi, Chung, Suk-Jae
Publicado 2022

Novel Dual-Targeting Antibody Fragment IDB0062 Overcomes Anti–Vascular Endothelial Growth Factor Drug Limitations in Age-Related Macular Degeneration

por Kim, Seongbeom, Min, Gihong, Kim, Bomin, Lee, Doseop, Lee, Myongjae, Ko, Jong-Hee, Kwon, Hyuk-Sang
Publicado 2021

Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers

por Shin, Dongseong, Park, Sang-In, Lee, Hong-Sub, An, Kyung-Mi, Jung, Juyoung, Lee, MyongJae, Yu, Kyung-Sang
Publicado 2019

Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety

por Lee, Myongjae, Je, In-Gyu, Kim, Jeong Eun, Yoo, Yeongran, Lim, Jong-Ha, Jang, Eunhye, Lee, Yoonsuk, Song, Dong Keun, Moon, An-Na, Kim, Jeong-Ah, Jeong, Jinah, Park, Joon-Tae, Lee, Jung Woo, Yang, Ji-Hoon, Hong, Chang-Hee, Park, Sun-Young, Park, Young-Whan, Baek, Nam Seok, Lee, Sungsook, Ha, Kyoung Soo, Choi, SungKu, Lee, Won Sik
Publicado 2023